ADYNCT06913075
FET in Adenomyosis
StatusNot Yet Recruiting
PhaseNot applicable
SponsorIndira IVF Hospital Pvt Ltd
Primary completion (estimated)
At risk: Primary completion moved 1 year 2 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below.
Notable Primary completion pushed from Jul 15, 2026 to Sep 15, 2027 Show 4 more changesShow less
- Start date: Jun 25, 2026 to Jan 16, 2027
- Study completion pushed from Dec 23, 2026 to Dec 23, 2027
- Secondary endpoints: details revised at 4 of 6 entries
- Publications: details revised at 5 of 5 entries
- Notable Primary completion date: Jul 15, 2025 to Jul 15, 2026
- Start date: Jun 25, 2025 to Jun 25, 2026
- Study completion date: Jan 23, 2026 to Dec 23, 2026
- Publications: details revised at 5 of 5 entries
- Notable Start date: Apr 25, 2025 to Jun 25, 2025v3
- Minor Site contact updatedv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Ongoing pregnancy rate
Timeframe: 12 weeks of gestation
Secondary (6)
Implantation Rate
Chemical Pregnancy rate
Biochemical loss rate
1st trimester loss
2nd trimester loss
Show 1 moreShow less
Live Birth Rate
Arms and interventions
Group AActive comparator
Group BActive comparator
Drugs: GnRH agonist downregulation, GnRH agonist and Letrozole
Sites
1 site in 1 country
- Indira IVF Pvt HospitalUdaipur, Rajasthan, India